Why is Jenburkt Pharma falling/rising?

As of 28-Aug, Jenburkt Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at Rs 1,090.00, which reflects a decrease of Rs 28.9 or 2.58%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 5.22% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 4.47%, and in the last month, it has seen a significant drop of 16.09%. Although there has been a rise in investor participation with a 36.04% increase in delivery volume, the overall sentiment appears negative, contributing to the stock's recent decline.
In the broader market context, Jenburkt Pharmaceuticals has underperformed relative to the Sensex, which has only declined by 2.34% over the past week. This stark contrast highlights the stock's weakness in comparison to the benchmark. Year-to-date, the stock is down 10.27%, while the Sensex has gained 2.48%, further emphasizing the challenges faced by Jenburkt Pharmaceuticals in the current market environment. The lack of available positive factors in the dashboard suggests that there are no significant catalysts to counterbalance the stock's recent poor performance, reinforcing the downward trend observed.